Cargando…

Characterizing the Relapse Potential in Different Luminal Subtypes of Breast Cancers with Functional Proteomics

Poor prognosis due to the high relapse and metastasis rates of breast cancer has been particularly linked to the luminal B subtype. The current study utilized MCF-7 and ZR-75-1 to investigate various luminal subtypes of breast cancers that have discrepant expressions in the estrogen receptor (ER) an...

Descripción completa

Detalles Bibliográficos
Autores principales:	Lin, Tung-Yi, Wang, Pei-Wen, Huang, Chun-Hsun, Yang, Pei-Ming, Pan, Tai-Long
Formato:	Online Artículo Texto
Lenguaje:	English
Publicado:	MDPI 2020
Materias:	Article
Acceso en línea:	https://www.ncbi.nlm.nih.gov/pmc/articles/PMC7504407/ https://www.ncbi.nlm.nih.gov/pubmed/32846884 http://dx.doi.org/10.3390/ijms21176077

Ejemplares similares

Comprehensive proteome, phosphoproteome and kinome characterization of luminal A breast cancer
por: Yang, Ganglong, et al.
Publicado: (2023)

CXCL12 and CXCR4 as Potential Early Biomarkers for Luminal A and Luminal B Subtypes of Breast Cancer
por: Motyka, Joanna, et al.
Publicado: (2023)

Characterization of Fibrinogen as a Key Modulator in Patients with Wilson’s Diseases with Functional Proteomic Tools
por: Wang, Pei-Wen, et al.
Publicado: (2019)

Using proteomic profiling to characterize protein signatures of different thymoma subtypes
por: Lai, Liang-Chuan, et al.
Publicado: (2019)

Luminal A and luminal B (HER2 negative) subtypes of breast cancer consist of a mixture of tumors with different genotype
por: Yanagawa, Masumi, et al.
Publicado: (2012)

Prognostic parameters of luminal A and luminal B intrinsic breast cancer subtypes of Pakistani patients
por: Hashmi, Atif Ali, et al.
Publicado: (2018)

Potential Benefits of Neoadjuvant Chemotherapy in Clinically Node-Positive Luminal Subtype(−) Breast Cancer
por: Kim, Hyung Suk, et al.
Publicado: (2019)

Characterization of Mitochondrial Proteome and Function in Luminal A and Basal-like Breast Cancer Subtypes Reveals Alteration in Mitochondrial Dynamics and Bioenergetics Relevant to Their Diagnosis
por: Ortega-Lozano, Ariadna Jazmín, et al.
Publicado: (2022)

Identification of a Novel Luminal Molecular Subtype of Breast Cancer
por: Dvorkin-Gheva, Anna, et al.
Publicado: (2014)

Ki-67 (30-9) scoring and differentiation of Luminal A- and Luminal B-like breast cancer subtypes
por: Viale, Giuseppe, et al.
Publicado: (2019)

Application of DCE-MRI radiomics signature analysis in differentiating molecular subtypes of luminal and non-luminal breast cancer
por: Huang, Ting, et al.
Publicado: (2023)

Comparison of the Biological Impact of UVA and UVB upon the Skin with Functional Proteomics and Immunohistochemistry
por: Wang, Pei-Wen, et al.
Publicado: (2019)

Association between Obesity, Race or Ethnicity, and Luminal Subtypes of Breast Cancer
por: Menikdiwela, Kalhara R., et al.
Publicado: (2022)

Functional Redox Proteomics Reveal That Salvia miltiorrhiza Aqueous Extract Alleviates Adriamycin-Induced Cardiomyopathy via Inhibiting ROS-Dependent Apoptosis
por: Hung, Yu-Chiang, et al.
Publicado: (2020)

The therapeutic response of ER+/HER2− breast cancers differs according to the molecular Basal or Luminal subtype
por: Bertucci, François, et al.
Publicado: (2020)

MRI texture analysis in differentiating luminal A and luminal B breast cancer molecular subtypes - a feasibility study
por: Holli-Helenius, Kirsi, et al.
Publicado: (2017)

A high-risk luminal A dominant breast cancer subtype with increased mobility
por: Guo, Liping, et al.
Publicado: (2019)

Proposed new clinicopathological surrogate definitions of luminal A and luminal B (HER2-negative) intrinsic breast cancer subtypes
por: Maisonneuve, Patrick, et al.
Publicado: (2014)

Young Age Is Associated with Increased Locoregional Recurrence in Node-Positive Breast Cancer with Luminal Subtypes
por: Kim, Sang-Won, et al.
Publicado: (2017)

Luminal B breast cancer subtype displays a dicotomic epigenetic pattern
por: Bediaga, Naiara G., et al.
Publicado: (2016)

FKBP4 is a malignant indicator in luminal A subtype of breast cancer
por: Xiong, Hanchu, et al.
Publicado: (2020)

A subset of activated fibroblasts is associated with distant relapse in early luminal breast cancer
por: Bonneau, Claire, et al.
Publicado: (2020)

Integrated Proteome and Cytokine Profiles Reveal Ceruloplasmin Eliciting Liver Allograft Tolerance via Antioxidant Cascades
por: Wang, Pei-Wen, et al.
Publicado: (2018)

Is There a Correlation between the Presence of a Spiculated Mass on Mammogram and Luminal A Subtype Breast Cancer?
por: Liu, Song, et al.
Publicado: (2016)

Association between mammographic density and basal-like and luminal A breast cancer subtypes
por: Razzaghi, Hilda, et al.
Publicado: (2013)

An integrated genomics approach identifies drivers of proliferation in luminal subtype human breast cancer
por: Gatza, Michael L., et al.
Publicado: (2014)

Association Between Insulin Resistance and Luminal B Subtype Breast Cancer in Postmenopausal Women
por: Nam, Sanggeun, et al.
Publicado: (2016)

MCM6 versus Ki-67 in diagnosis of luminal molecular subtypes of breast cancers
por: Sadeghian, Dorsay, et al.
Publicado: (2022)

RNA m(6)A Methylation Regulators Subclassify Luminal Subtype in Breast Cancer
por: Yang, Lin, et al.
Publicado: (2021)

Luminal androgen receptor breast cancer subtype and investigation of the microenvironment and neoadjuvant chemotherapy response
por: Thompson, Kevin J, et al.
Publicado: (2022)

Quantification of subtype purity in Luminal A breast cancer predicts clinical characteristics and survival
por: Kumar, Neeraj, et al.
Publicado: (2023)

Luminal B subtype: A key factor for the worse prognosis of young breast cancer patients in China
por: Tang, Li-Chen, et al.
Publicado: (2015)

Metabolic profiles of triple-negative and luminal A breast cancer subtypes in African-American identify key metabolic differences
por: Tayyari, Fariba, et al.
Publicado: (2018)

Timescale of tumor volume of a young breast cancer patient with luminal B subtype: A case report
por: Mao, Xiaoyun, et al.
Publicado: (2019)

Spectrum of MAP3K1 mutations in breast cancer is luminal subtype-predominant and related to prognosis
por: Li, Cheukfai, et al.
Publicado: (2022)

Proteome-based identification of apolipoprotein A-IV as an early diagnostic biomarker in liver fibrosis
por: Wang, Pei-Wen, et al.
Publicado: (2017)

Clinical and prognostic profile of Her2neu positive (non-luminal) intrinsic breast cancer subtype: comparison with Her2neu positive luminal breast cancers
por: Hashmi, Atif Ali, et al.
Publicado: (2018)

Difference between Luminal A and Luminal B Subtypes According to Ki-67, Tumor Size, and Progesterone Receptor Negativity Providing Prognostic Information
por: Inic, Zorka, et al.
Publicado: (2014)

Proteome of the Luminal Surface of the Blood–Brain Barrier
por: Hill, Jennifer J., et al.
Publicado: (2021)

A mouse model for Luminal epithelial like ER positive subtype of human breast cancer
por: Kumar, MJ Mahesh, et al.
Publicado: (2007)

Cannot write session to /tmp/vufind_sessions/sess_r9c74tfq44d5vkup0fq5eub1vl